April 14, 2021
Business News

DiaMedica Therapeutics to Report Fourth Quarter 2020 Financials and Provide a Business Update March 11, 2021

MINNEAPOLIS–()–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that its fourth quarter 2020 financial results will be released after the markets close on Wednesday, March 10th. DiaMedica will host a live conference call on Thursday, March 11th at 7:00 AM Central Time to discuss its business update and financial results.

Conference Call details:

Interested parties may access the conference call by dialing in or listening to the simultaneous webcast. Listeners should log on to the website or dial in 15 minutes prior to the call. The webcast will remain available for play…

Click here to view the original article.

Related Posts

You might also like ...

Spark NZ Selects Calabrio as Part of Unified Front Line Initiative
AlixPartners Disruption Index Reveals That Business Leaders Don’t Consider COVID-19 to Be the Most Disruptive Force Impacting Their Organization
Germany’s Supreme Court Rules in Solvay’s Favor on Patent Case With Neo